breast cancer
Let an agent give accurate general information on breast cancer, encourage screening and prompt assessment of changes, explain diagnosis and treatment pathways in general terms, and point to specialist care and support without individual medical advice.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent give accurate general information on breast cancer, encourage screening and prompt assessment of changes, explain diagnosis and treatment pathways in general terms, and point to specialist care and support without individual medical advice.
A cancer that forms in the tissues of the breast, most commonly in the ducts or lobules, affecting mainly women but also men, with types ranging from ductal carcinoma in situ to invasive and metastatic disease; it is the most common cancer in women worldwide, detected by screening and symptoms, and treated with surgery, radiotherapy, chemotherapy, hormone and targeted therapies.
What it is for: A cancer requiring screening, diagnosis, treatment and support.
It can be explain symptoms and screening; describe types and stages in general terms; explain treatment pathways and genetic risk; find specialist centres and patient organisations.
Distinguishing features
Breast tissue origin
Several subtypes by receptors
Screening-detectable
Hereditary risk in some families
What it looks like
Not physical as a concept; a diagnosis from imaging and pathology.
How it is recognised
Breast lumps, skin or nipple changes
Diagnosed by mammography, ultrasound and biopsy
Most breast lumps are benign
Related models
is a kind of - category
is a kind of - category
is treated by - services
is related to - shared hereditary risk
In practice
Families and kinds
ductal carcinoma in situ
invasive ductal and lobular carcinoma
hormone receptor positive, HER2 positive and triple negative subtypes
metastatic breast cancer
male breast cancer and rare types such as phyllodes tumours
Standards and regulation
Clinical guidelines from oncology societies
National screening programmes
Genetic testing guidelines for BRCA variants
Failure modes and hazards
Delayed assessment of symptoms
Agents giving individual medical advice
Unproven treatments
Also called
+10
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Symptoms Changes to check.
Prompt assessment.
Changes
Breast changes.
Changes
Changes.
- Has the person noticed a lump, skin change, nipple discharge or other breast change? boundary
- Should they see a doctor promptly for assessment? action
Screening
Screening programmes.
Screening
Screening.
- Who is invited for screening here, at what ages and intervals? provenance
- What are the benefits and limitations of screening, according to health authorities? provenance
Understand The disease.
General information.
Types
Types and stages.
Types
Types.
- What type, subtype and stage is being discussed, in general terms? definition
- Is the user asking about their own diagnosis or results? boundary
Risk
Risk factors.
Risk
Risk factors.
- What do health authorities say about risk factors and hereditary variants? provenance
- Who is eligible for genetic counselling? provenance
Treatment Care pathway.
Specialist care.
Pathway
Diagnosis and treatment.
Pathway
Pathway.
- How is breast cancer diagnosed and treated, according to guidelines, in general terms? provenance
- Which questions should be asked of the oncology team? action
Trials
Clinical trials.
Trials
Trials.
- Which trials are recruiting, according to registries? provenance
- How can a patient discuss trials with their team? action
Support Living with it.
Support helps.
Organisations
Patient groups.
Organisations
Patient groups.
- Which patient organisations support people with breast cancer here, including men? provenance
- Which services do they offer? provenance
Life
After treatment.
Life
After treatment.
- What follow-up and survivorship support is available? provenance
- How can carers be supported? provenance
What the second pass must settle
- Should each subtype be a separate entry?
- How should screening programmes be localised?
- How should support organisations be linked?